trending Market Intelligence /marketintelligence/en/news-insights/trending/ud7znkdm77ionxu5y5ia6q2 content esgSubNav
In This List

LexaGene Holdings names director

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


LexaGene Holdings names director

LexaGene Holdings Inc. appointed Joseph Caruso as a board member.

Caruso currently serves as a board member of Endocellutions Inc., a privately held medical device company. He was a member of Launchpad Venture Group, a Boston-based investment group providing funding and advice to early stage companies, from 2016 to 2018.

Lexagene Holdings engages in the research, development and commercialization of pathogen detection devices to the bio-chemical industry in the U.S.